Skip to main content Back to Top
Advertisement

1/30/2020

Metronidazole Hydrochloride Injection

Products Affected - Description

    • Metronidazole hydrochloride solution for injection, Baxter, 5 mg/mL, 100 mL bag, 24 count, NDC 36000-0001-24
    • Metronidazole hydrochloride solution for injection, Pfizer, 5 mg/mL, 100 mL bag, 24 count, NDC 00409-7811-24

Reason for the Shortage

    • Baxter did not provide a reason for the shortage.
    • BBraun has metronidazole injection available.
    • Pfizer has metronidazole injection available.
    • Sagent launched metronidazole injection in October 2019.

Available Products

    • Metronidazole hydrochloride solution for injection, BBraun, 5 mg/mL, 100 mL bag, 24 count, NDC 00264-5535-32
    • Metronidazole hydrochloride solution for injection, Baxter, 5 mg/mL, 100 mL bag, 24 count, NDC 00338-1055-48
    • Metronidazole hydrochloride solution for injection, Pfizer, 5 mg/mL, 100 mL bag, 80 count, NDC 00409-7811-37
    • Metronidazole hydrochloride solution for injection, Sagent, 5 mg/mL, 100 mL bag, 24 count, NDC 25021-0131-82

Estimated Resupply Dates

    • Baxter has metronidazole 100 mL bags (NDC 36000-0001-24) on back order and the company cannot estimate a release date.
    • Pfizer has metronidazole 100 mL bags in 24 count available in limited supply.

Updated

Updated January 30, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 8, 2017 by Leslie Jensen, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins